Viatris Inc. Profile Avatar - Palmy Investing

Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Drug Manufacturers - Specialty & Generic
US, Canonsburg [HQ]

Ratios

16 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 None
Profitability
Gross Margin
40.73 40.68 41.82 42.79 44.00 45.70 44.71 42.40 40.17 35.00 33.89 31.78 31.17 39.95 - - 42.70
Profit Margin
4.57 6.33 8.76 9.43 9.03 12.04 8.99 4.33 5.84 3.08 0.15 -5.61 -7.10 12.78 - - 0.36
Operating Margin
10.28 13.24 16.40 16.32 16.44 17.52 15.49 6.33 12.07 7.92 -11.90 -0.95 -23.51 2.58 - - 13.35
EPS Growth
151.67 122.58 81.16 23.20 5.84 52.76 -27.71 -47.78 38.30 -46.92 -95.28 -3,504.91 5.41 262.86 - - -97.33
Return on Assets (ROA)
2.15 2.99 4.63 5.37 4.09 5.85 3.81 1.38 1.94 1.08 0.05 -1.09 -2.31 4.16 - - 0.11
Return on Equity (ROE)
7.43 9.58 15.37 19.18 21.20 28.55 8.68 4.32 5.23 2.90 0.14 -2.92 -6.19 9.86 - - 0.27
Return on Invested Capital (ROIC)
6.87 7.75 9.41 9.77 8.68 10.98 7.89 10.40 3.96 4.11 -0.61 -0.21 -19.09 0.77 - - 1.43
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
47.95 47.09 45.69 48.06 52.70 53.74 33.12 44.61 40.98 42.34 40.71 42.42 39.38 38.53 - - 38.20
Debt/Equity
165.40 150.84 151.75 171.65 272.96 262.23 75.52 139.37 110.27 113.92 107.06 113.74 105.38 91.47 - - 88.99
Debt/EBITDA
614.69 542.20 314.68 449.44 495.42 406.26 437.15 1,160.46 1,009.62 1,702.84 1,883.25 1,201.52 6,941.33 522.70 - - 367.40
Debt/Capitalization
62.32 60.13 60.28 63.19 73.19 72.39 43.03 58.22 52.44 53.25 51.70 53.21 51.31 47.77 - - 47.09
Interest Debt per Share USD
18.01 17.77 13.08 14.55 21.77 23.74 16.33 31.09 28.45 27.99 25.67 44.26 18.39 16.39 - - 15.65
Debt Growth
-3.49 5.59 0.67 0.73 50.45 -28.61 9.82 146.09 -5.28 -5.54 -8.21 105.22 -17.29 -10.75 - - -4.64
Liquidity
Current Ratio
191.22 196.70 139.24 177.92 151.26 127.92 157.02 149.24 112.97 138.80 121.34 121.82 110.30 157.65 - - 157.24
Quick Ratio
95.61 102.13 71.48 87.86 72.34 47.54 96.53 88.98 64.27 73.25 65.42 55.78 52.62 78.37 - - 65.84
Cash Ratio
22.15 36.59 14.63 15.95 9.85 4.25 29.98 19.81 4.57 8.46 8.54 7.99 7.09 18.68 - - 12.78
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
270.89 260.68 255.34 254.90 232.40 253.82 267.21 259.73 280.20 288.05 284.66 148.93 309.50 277.47 - - 254.02
Receivables Turnover
412.49 471.06 429.73 437.23 379.57 340.30 350.65 334.56 329.63 396.87 375.98 246.63 419.24 426.34 - - 380.68
Payables Turnover
582.40 572.53 507.15 499.78 360.61 462.85 469.83 679.07 729.98 661.71 715.97 605.58 1,165.69 843.33 - - 638.03
Asset Turnover
47.15 47.24 52.85 56.96 45.35 48.59 42.35 31.90 33.26 34.93 36.80 19.41 32.61 32.51 - - 32.26
Coverage
Interest Coverage
164.32 217.70 299.29 359.36 362.40 405.94 430.44 154.27 268.82 166.99 -264.64 -22.78 -661.03 70.70 - - 357.12
Asset Coverage
100 100 100 100 100 100 100 100 100 100 100 - - - - 100 - - 100
Cash Flow Coverage (CFGR)
11.68 17.14 13.60 16.55 13.78 11.89 27.24 13.21 14.07 16.89 14.18 4.72 13.97 15.32 - - 15.37
EBITDA Coverage
200 200 400 300 400 400 300 200 200 100 100 400 - - 500 - - 800
Dividend Coverage
-100 -200 - - - - - - - - - - - - - - - - - - - - 300 -300 - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 - - 100 100 - - 100
Market Prospects
Dividend Yield
2.47 2.03 - - - - - - - - - - - - - - - - - - - - 2.44 4.31 - - 4.43
Earnings Yield
4.14 5.03 5.81 5.62 3.75 4.41 3.32 2.45 3.08 2.50 0.16 -5.95 -7.76 15.41 - - 0.42
Price/Earnings (P/E)
2,418.24 1,986.49 1,722.36 1,778.50 2,667.14 2,266.57 3,012.25 4,077.28 3,249.24 3,999.23 61,699.82 -1,681.82 -1,288.71 649.03 - - 23,764.62
Price/Book (P/B)
179.62 190.34 264.79 341.17 565.47 646.99 261.48 176.06 169.94 115.86 87.22 49.08 79.81 64.02 - - 63.51
Price/Sales (P/S)
110.43 125.78 150.83 167.71 240.77 272.88 270.77 176.68 189.92 123.29 90.13 94.31 91.44 82.95 - - 84.51
Price/Cash Flow (P/CF)
929.49 736.06 1,283.38 1,200.98 1,503.32 2,075.82 1,271.19 955.99 1,095.25 602.01 574.68 914.64 542.11 456.91 - - 464.33
End of VTRS's Analysis
CIK: 1792044 CUSIP: 92556V106 ISIN: US92556V1061 LEI: - UEI: -
Secondary Listings
VTRS has no secondary listings inside our databases.